Introduction to Calcifying Pseudoneoplasms of the Neuraxis (CAPNON)

Calcifying pseudoneoplasms of the neuraxis (CAPNON) represent a rare and fascinating diagnostic challenge for neurologists and neurosurgeons. These lesions are primarily slow-growing and non-neoplastic in nature. Despite their name, they are not true tumors but are often considered reactive or fibro-osseous lesions. They can manifest anywhere along the central nervous system, including intracranial and spinal locations. However, their presence at the foramen magnum or cervicomedullary junction is exceptionally uncommon. Clinicians must distinguish these benign masses from more aggressive malignancies to prevent unnecessary treatments. The rarity of the condition is highlighted by the fact that only about 150 cases appear in global medical literature. Understanding the unique markers of calcifying pseudoneoplasms neuraxis (CAPNON) is essential for optimizing patient care. This article discusses a specific case study and provides a comprehensive review of the current literature regarding this pathology. By examining the clinical, radiological, and histological aspects, we can better understand how to manage this "great mimicker." Recognition of these lesions avoids the pitfalls of assuming a malignant process when a curative surgical option is available.

Clinical Presentation and Diagnostic Symptoms

The clinical presentation of these rare lesions depends heavily on their specific anatomical location. In the recently reported case, a 35-year-old male patient presented with a six-month history of persistent neck pain. Over the subsequent three months, his condition progressed to include frequent headaches, nausea, and blurred vision. Upon clinical examination, physicians identified bilateral papilledema, which suggested significantly increased intracranial pressure. Interestingly, the patient's neurological examination revealed no focal motor or sensory deficits. This lack of neurological deficits is common in slow-growing lesions of the foramen magnum until they reach a critical size. Consequently, patients might endure symptoms for months before seeking advanced neuroimaging. The foramen magnum is a high-stakes region where the brainstem transitions into the spinal cord. Compression in this area can lead to sudden respiratory failure or profound tetraparesis if not addressed. However, the benign growth of CAPNON often allows for a more gradual clinical onset compared to aggressive gliomas. The patient's symptoms were primarily related to the mass effect on the cervicomedullary junction. Early diagnosis remains key to preventing permanent neural damage in such sensitive locations.

Radiological Characteristics of Calcifying Pseudoneoplasms Neuraxis (CAPNON)

Radiology serves as the first line of defense in identifying calcifying pseudoneoplasms neuraxis (CAPNON). On computed tomography (CT) scans, these lesions typically appear as heavily calcified, well-circumscribed masses. This dense calcification is a hallmark feature that differentiates them from many other soft tissue tumors. Magnetic resonance imaging (MRI) provides further detail regarding the lesion's relationship with surrounding neural structures. Typically, CAPNON exhibits a low signal intensity on both T1 and T2-weighted sequences. This "black hole" appearance on MRI is due to the intense mineral content within the mass. Furthermore, these lesions often show minimal or no internal contrast enhancement. Some cases may exhibit a thin peripheral rim of enhancement, reflecting the surrounding fibrovascular capsule. In the case at the foramen magnum, MRI showed a right-sided intra-dural extramedullary tumor. The differential diagnosis for such a presentation includes calcified meningiomas, schwannomas, or even chordomas. However, the specific combination of heavy calcification and a lack of significant enhancement should prompt suspicion of CAPNON. Accurate radiological interpretation is vital for planning the surgical approach and preparing the pathology team for intraoperative consultation.

Histopathological Markers and Pathogenesis

Definitive confirmation of CAPNON always requires a detailed histopathological analysis. Pathologists look for a specific set of features that define this entity. A characteristic chondromyxoid matrix with a nodular pattern is frequently observed. Surrounding these nodules, one often finds palisading spindle or epithelioid cells. In addition, the lesions usually contain varying amounts of fibrous stroma and prominent calcifications. Psammoma bodies and areas of ossification or bone formation are also common findings. In some instances, a foreign-body giant cell reaction may be present, which supports the hypothesis that CAPNON is a reactive inflammatory process. Some researchers suggest that these lesions arise in response to trauma, infection, or chronic inflammation. Immunohistochemical staining can further assist in the diagnosis. For example, the spindle cells typically stain positive for vimentin and sometimes epithelial membrane antigen (EMA). Notably, the absence of high mitotic activity or necrosis helps rule out malignant neoplasms. These histological findings are consistent across most reported cases in the literature. They provide the necessary evidence to classify the mass as a benign pseudoneoplasm rather than a true cancer.

Surgical Management and Prognostic Outcomes

The standard of care for symptomatic CAPNON is complete surgical resection. Because these lesions are benign and well-demarcated, surgeons can often achieve gross total removal. In the discussed case, the patient underwent a midline suboccipital craniotomy with a C1 laminectomy. This approach allowed for excellent visualization of the foramen magnum and the cervicomedullary junction. The surgical team successfully resected the mass entirely without causing any new neurological deficits. Because resection is generally curative, there is no requirement for post-operative chemotherapy or radiation therapy. This is a critical point for clinicians to communicate to patients, as it significantly changes the long-term outlook. The prognosis following successful surgery is excellent, with a very low rate of recurrence reported in the literature. Most patients experience a complete resolution of their preoperative symptoms, such as headaches and neck pain. Long-term follow-up remains necessary to monitor the surgical site, but the risk of aggressive behavior is negligible. This case reinforces the idea that radical surgery remains the primary therapeutic pillar for these rare calcified entities.

Literature Review and Future Perspectives

A review of the approximately 150 reported cases of CAPNON reveals that they can occur at any age, although they are most common in middle-aged adults. While the supratentorial compartment is the most frequent site, spinal and skull base locations are also documented. The foramen magnum remains one of the rarest sites for this pathology. Most literature reviews emphasize that CAPNON is often misdiagnosed preoperatively as a meningioma or an osteoma. Improving the awareness of its unique radiological signature—intense calcification with low MRI signal—can help refine the preoperative diagnosis. Future research may focus on the molecular triggers that lead to such extensive calcification in the neuraxis. Understanding whether specific genetic predispositions exist could offer deeper insights into its pathogenesis. Currently, the medical community relies on individual case reports to build a collective understanding of this rare condition. Each new report, like the one at the cervicomedullary junction, adds valuable data points regarding surgical challenges and long-term stability. For neurosurgeons in India and globally, maintaining CAPNON in the differential for calcified CNS lesions is crucial for delivering high-quality, evidence-based care.

Frequently Asked Questions

Is CAPNON considered a true malignancy?

No, CAPNON is a benign, non-neoplastic lesion and does not exhibit malignant behavior or metastatic potential. Although it can cause significant neurological symptoms due to its size and location, it is essentially a slow-growing calcified mass. Surgical removal is generally curative, and the long-term prognosis for patients is excellent.

What are the hallmark radiological features of CAPNON?

The hallmark radiological features include heavy calcification on CT scans and low signal intensity on T1 and T2-weighted MRI sequences. These lesions are typically well-circumscribed and show minimal to no internal contrast enhancement. These findings are critical for differentiating CAPNON from more aggressive neoplastic conditions like malignant gliomas.

What is the standard treatment for symptomatic CAPNON lesions?

The primary treatment for symptomatic CAPNON is gross total surgical resection. Because the lesion is benign, complete removal is usually sufficient to prevent recurrence and resolve mass effect. Adjuvant therapies, such as chemotherapy or radiation, are not required. In asymptomatic cases, observation with periodic imaging may be considered.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Atallah O et al. Calcifying pseudoneoplasms of the neuraxis (CAPNON) in foramen magnum (cervicomedullary junction) region: a case report and review of the literature. Br J Neurosurg. 2025 Oct. doi: 10.1080/02688697.2024.2339354. PMID: 38616542.

Ho ML et al. New insights into calcifying pseudoneoplasm of the neuraxis (CAPNON): a 20-year radiological–pathological study of 37 cases. Histopathology. 2020 Jun;76(7):1055-1069. doi: 10.1111/his.14088.

Aiken AH et al. Calcifying pseudoneoplasms of the neuraxis: CT, MR imaging, and histologic features. AJNR Am J Neuroradiol. 2009 Aug;30(7):1256-60. doi: 10.3174/ajnr.A1524.